Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Follow-Up Questions
BNR 주식의 가격 성능은 어떻습니까?
BNR의 현재 가격은 $8.41이며, 전 거래일에 decreased 0% 하였습니다.
Burning Rock Biotech Ltd의 주요 사업 주제나 업종은 무엇입니까?
Burning Rock Biotech Ltd은 Biotechnology 업종에 속하며, 해당 부문은 Health Care입니다
Burning Rock Biotech Ltd의 시가총액은 얼마입니까?
Burning Rock Biotech Ltd의 현재 시가총액은 $86.2M입니다
Burning Rock Biotech Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 2명의 분석가가 Burning Rock Biotech Ltd에 대한 분석 평가를 실시했으며, 이는 1명의 강력한 매수, 3명의 매수, 1명의 보유, 0명의 매도, 그리고 1명의 강력한 매도를 포함합니다
